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done in order to patent this product for use. 
       
If you have any questions or concerns with the content of this document, please feel free to email 
our Communications Officer, Sara Parker, at sparke26@vols.utk.edu 
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EXECUTIVE SUMMARY  
       
The proposed device design is intended to streamline anastomosis procedures while improving 
efficacy and duration of the newly formed connection. The device will consist of a conduit upon which 
two intestinal canals may be mounted and a male-and-female clamp which will fix the intestines onto the 
device. The clamp will be used to further secure the mechanical fixation of our device and to provide 
external support as another layer of defense against failure. Our device design will facilitate material flow 
on the interior of the device and the union of two mounted tissue segments on the exterior surface. The 
material that is selected for our final design is 85:15 PLGA, which is biocompatible and will degrade in 5-
6 months.  
      
This design will allow for a reliable mechanical fixation supported by an additional chemical 
fixation by way of the tissue adhesive, BioGlue. This double fixation will ensure the integrity of the graft-
tissue attachment. Additionally, the BioGlue is intended to stimulate the growth of the two tissue 
segments until union. This should ensure the longevity of the anastomosis. Avoidance of occlusion 
events, a facet of many anastomotic devices that is short-lived, should be achieved by the biodegradable 
nature of the main conduit. This will allow for internal disposal of the device without the need of 
additional intervention. Once the device is disposed, all that remains will be the newly formed, continuous 
tissue connection. The clamp is designed as a hinge, so that it can be easily applied around the tissues 
without causing further damage. This directly relates to necrosis avoidance by the graft and target tissues. 
These aspects will ensure the reliability of the graft-to-target connection, the longevity of the union, the 
avoidance of occlusion events, and the survival of the involved tissues per stakeholder requirements.  
    
As anastomosis procedures are performed for tubular tissue connections, a device or device 
system that streamlines the anastomotic process, reduces occlusion risk, and ensures connection efficacy 
would find application within many anastomotic procedures. This is a relatively large market to be 
explored as current devices are only applicable to tissue specific anastomotic procedures and come with 
many of the previously mentioned pitfalls. Our design may be applicable to many anastomotic procedures 
after material composition adjustments that would account for varied body environments. The base 
conduit connection design would remain consistent throughout the tissue specific iterations. This would 
allow for a standardization of anastomotic procedures and reduce the training required to master such a 
technique.  
 
The prototype meets and surpasses all of the requirements of the manufacturing specifications. 
The prototype has been manufactured in the manner that was described and by ProtoLabs, the company 
that was selected. This prototype exceeds the requirements because the clamp has been modified to 
include a hinge to make the application of the hinge less damaging to the tissue. The prototype has been 
manufactured under budget, the time that it takes to complete implement is very quick (roughly 3 
minutes), and it has a lower failure rate than staples/hand suturing in our testing. Testing of our device 
included tensile tests with and without the conduit, and leakage tests. Our final device will be 
biocompatible and sterilizable. This prototype fulfills all of our design needs provided by our stakeholder. 
These needs include efficacy, ease of use, biocompatibility, easy on tissue, adjustable/applicable to 
varying tissue sizes, and it will be degradable.   
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BACKGROUND      
       
An anastomosis is any surgical connection between two tubular structures such as blood vessels 
or intestines. Currently, anastomosis procedures are performed by hand-suturing or stapling the ends of 
the vessels together. While the more recent development of gastric staplers has made the anastomosis 
process easier, most of the associated risks remain.1 There are many complications associated with both 
of these methods, including bleeding, leakage, and stricture.1 In fact, most studies have not found a 
significant difference between suturing and stapling with respect to the associated risks.1-6 For 
gastrointestinal anastomosis, anastomotic leakage is a major complication. Depending on the region in 
which re-sectioning is performed, leakage rates range anywhere between 0.5-20%.7-12 Further, the 
morbidity rate following leakage has been shown to range from 20%-30% and the mortality rate ranges 
from 7% to 14% (compared to an overall mortality of about 4%).7,8,13-16 In addition to leakage, stricture is 
a major complication of anastomosis procedures, specifically those that involve stapling. Stricture after 
staple procedures are estimated to occur in approximately 3 to 30% of all colorectal anastomoses; further, 
about 28% of these cases require an additional procedure.17 It is important to note that the wide ranges of 
complications in anastomosis procedures is attributed to patient variation and discrepancies among 
surgeons.8,17 Compounding the effect of the occurrence of adverse events, gastrointestinal anastomosis 
procedures need to be performed for a variety of reasons including gastric bypass procedures, colorectal 
cancer (the second most common type of cancer), bacterial infections or gangrene, ulcerative colitis, 
Irritable Bowel Disease, and Crohn’s Disease. Thus, because of the frequency at which anastomosis 
procedures are performed and the severe risk incurred when the connection fails, it is imperative that 
efficate, novel, and standardized solutions be explored. A comprehensive list of relevant patents and 
devices can be found in APPENDIX A. 
 
With respect to a new device for anastomosis procedures, there are a number of needs presented 
by the project stakeholder. Most importantly the device must be effective by providing a stable 
connection between two vessels without leaking or blocking. A device that is not as effective as the 
current method would be a waste of time and money. The next essential need for this device is the ease of 
use. Most surgeons will not want to use or be trained with a product that is not easy to use. An additional 
need is biocompatibility. When a foreign material is used during the procedure or left in the body, the 
material must not elicit a foreign body response. Additionally, the device must be compatible with various 
intestine sizes. Finally, the device must not be too hard on the tissue, causing additional damage. 
Following the “needs”, other crucial factors when creating an anastomosis device are the “wants”. These 
features are desirable, but not completely necessary for the device’s success. The primary want expressed 
to us by the project stakeholder (Dr. Lee) is a sutureless method for anastomosis procedures. This could 
prevent excessive damage to the underlying tissue, thereby, decreasing the inflammatory response and 
chance of stricture. Another important “want” that was expressed is comfortability. If the device is not 
comfortable to use, it would be difficult to convince surgeons that our device is superior to other methods. 
The final “want” is for the device to be low cost. This is considered a “want” because the device may be 
more effective than hand-suturing, while being more expensive to produce.  
   
A viable design solution that improves on current anastomosis methods has many health 
implications. Decreasing the time it takes for surgeons to perform the procedure will minimize the time 
needed for the patient to be under anesthesia. Additionally, if a device or material could be used to create 
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the anastomosis instead of hand suturing, the procedure method could be better standardized across all 
surgeons. This would limit the subjectivity and human error associated with this procedure, and 
ultimately improve the success rate. In addition, a more standardized procedure would create a system 
where failures can be clearly documented and it will be easy to identify device shortcomings and human 
error, allowing the designers to create a better device in the future. The main people that would benefit 
from this device are gastrointestinal surgeons, because the surgery would be easier to perform and execute 
correctly. All patients that must undergo a procedure of this nature would benefit from this, as well 
because success rates would improve.             
 
 
PROBLEM DEFINITION 
       
The goal of the project is to design a device that will make the anastomosis procedure easier, 
improve overall success rates by limiting blockages and leakages, and standardize anastomosis 
procedures. Our key business objectives are productivity, marketing, and competitive analysis. By 
grounding our project in these objectives, we will produce a high-quality design that can be marketed and 
outcompete competitor products. 
  
Based on the aforementioned needs, the following table is a list of functions and requirements 
that the device must satisfy to be considered successful and how success will be measured for each of 
these requirements (Table 1). Here, efficacy refers to the device’s ability to form a stable connection 
without leaking. This required function will be measured by analyzing the leakage rates of fluids with 
varying viscosity through the site of connection. The needs will be satisfied if the solution is efficate and 
there is no leakage at the anastomosis site. Another major function of the design is ease of use. Users 
must be able to use the device easily, without complication and extensive training. To ensure that this 
function is satisfied, the time of application will be measured and compared to the expected ~3 minute 
time of conventional suture and staple-based methods. Further, a standardized procedure and result should 
be established to ensure that human error is not a factor. The standardization function will be measured by 
observing the efficacy and ease of use function across multiple users. Lastly, biocompatibility of the 
solution (and the ability of the product to biodegrade) is a requirement that must be satisfied. This will be 
ensured by analyzing and reviewing standards and specifications for biomedical devices and studying 
common biomaterials used for this application. This function is vital to the device’s success because it is 
intended to be used in the body. Thus, an incompatible material will not be accepted.  
 
 Specific constraints as outlined by the project guidelines include time, cost, biocompatibility and 
efficacy. With only 6 months to refine, manufacture, and test the design, time is a major factor affecting 
design selection and refinement. In addition, the budget for the project is only $3,000, so cost is a 
significant limitation that will need to be overcome. Because the device will require placing foreign 
materials into the body, the sterilization requirement is another constraint that may limit material 
selection. Each of the constraints may limit the materials and manufacturing processes that are available. 
Further, the device is expected to keep the anastomosis site open, without causing harm to the tissue. 
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Table 1. Function Breakdown Table. Listed are specific functions that correspond with 
stakeholder needs. The “Metric” column refers to the way that each of the listed functions will 
be measured to determine if the device is successful.  
 
Function  Metric 
Efficacy Examine volume of leaked fluid during testing 
Ease of Use Comparison of procedure time to the expected time for 
current methods.  
Standardization Measure efficacy and ease of use across multiple users 
Biocompatibility Analysis of literature/standards  
      
 
Societal expectations are primarily concerned with safety. The safety of the device can be ensured 
if the functions and requirements are appropriately fulfilled. The primary function that would address the 
issue of safety is efficacy. Here, efficacy ensures that the device will work and will not cause adverse 
health events (caused by infection or device failure) and will not cause further damage. In addition to 
safety, there has been a recently growing societal expectation of the biomedical industry improving 
quality and length of life. This expectation has been primarily driven by biomedical research and 
advancement. Consequently, this device is expected to contribute to this trend by having long-term 
efficacy and thereby improving overall health outcomes. Another societal concern is the cost burden. 
With the high cost and uncertainty associated with health insurance along with the continued 
globalization of the biomedical marketplace, the device is expected to be relatively cheap and accessible 
to all. The solution is therefore expected to have economic benefit over pre-existing methods and other 
competitors. Lastly, the device is expected to confer with legal and ethical standards that would allow its 
utilization without conflict. Ethically, the device should ensure sufficient safety and undergo appropriate 
clinical trials before implementation so as to abide by the Code of Ethics and FDA regulations. To 
coincide with safety and ethical regulations, the rights and respect of human and animal subjects must be 
maintained. Sufficient simulations should be performed where appropriate, so as to prevent unnecessary 
subject testing. Further, patient confidentiality must be maintained throughout the design and testing 
process.  
 
The sources of project learning can be divided into two categories: research and action. The 
research component consisted of gathering knowledge from various sources including the stakeholder, 
professors, journal articles, and books. These sources helped lay the foundation for attaining all of the 
background information necessary for product success. This includes information about current 
anastomosis methods, biological information, novel products, and overall design recommendations. 
Following appropriate research, the team relied on experimentation for continued learning. This entailed 
experimenting with porcine intestine to learn about its size and mechanical properties. This allowed the 
team to produce rudimentary prototypes to analyze behavior and performance. With this information, the 
design could draw conclusions about the design, and the device could continue to be refined and 
optimized.  
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CONCEPT DEVELOPMENT          
            
By analyzing the product landscape and comparing the successful and unsuccessful products, we 
decided on several different ways that we could approach the problem of performing anastomosis 
procedures. We explored each potential design solution to decide which design would create the best 
outcome while still remaining reliable and easy to use. We knew that we had a major time constraint to 
keep in mind, since we would only have one semester (roughly four months) to manufacture and test this 
product. We utilized the flowchart below (Figure 1) showing different approaches to the anastomosis 
problem to help us brainstorm different solutions that we could create for this unique design problem.  
 
Figure 1. Flow Diagram of Design Concepts Considered. The design concepts could be 
divided into two broad mechanisms: mechanical fixation and adherence. Both of these 
attachment mechanisms could be further categorized as shown.  
 
After extensive research, we devised two overall mechanisms for performing anastomosis 
procedures: mechanical fixation and adherence. The mechanical fixation method includes solutions such 
as sutures, staples, and hooks that would cinch or mechanically hold the ends of the intestines together. In 
cases that did not entail end-to-end anastomosis procedures, this mechanism would require a procedure to 
ensure appropriate hole and/or vessel size (such as a hole punch). In addition to mechanical fixation, the 
team also identified adherence as a potential mechanism for attachment. This could potentially entail 
gluing or welding the tissues together. With the adherence methods, however, a balloon or stent would 
likely be needed to provide stability to the underlying tissue. With this general outline, many solutions 
were considered within a complex construct; however, the best concepts either met a number of 
fundamental needs in a simple way or met all needs with a more complicated system. These two 
categories arose as front runners as a result of the simplistic ideology comprised of what will get the job 
done to an acceptable degree and above. 
       
The first proposed concept was a T-shaped balloon that would be inserted through a hole in the 
vein graft and lowered down into an incision in the coronary artery for an end-to-side anastomosis. Once 
the balloon was inserted into the coronary artery, it would then be inflated and a BioGlue would be 
applied to the connecting point. However, for the device to be successful, it would need to be ensured that 
 
Final Design Report                          Team Connect 
7 
the same length cut was made each time on the vessels. This led to a secondary potential design idea: 
inverse scissors. A pair of inverse scissors with blades on the outside and a locking mechanism that would 
allow for the blade to only open a certain length each time would allow for the same cut to be made each 
time. 
       
With the goal of meeting the designated requirements, the concept of a “Reinforced Fixation 
Anastomotic Punch” was proposed for use in side-to-side anastomoses. This device would meet the 
requirements of ease of use, efficacy, biocompatibility and longevity through its multi-component 
approach. It would utilize a handheld device portion in conjunction with a surgeon placed anchor. The 
handheld portion would consist of a front graft vessel loading port, internal hole punch, topside bioactive 
adhesive canister dock, internal extrusion pathway, bottom face extrusion ports, and a button activated 
deployment system. The anchor would be inserted into the target vessel by the surgeon after an initial 
incision. It would then be grasped by prongs on the handheld device portion and thrust upward when the 
internal hole punch becomes activated. A mechanical fixation would be activated in coordination with the 
extrusion of the bioactive adhesive. The hole punch ensures that the holes created on the graft and target 
vessels are of the same proportions. The inserted anchor protects the opposite wall of the target vessel 
from puncture while also acting as the lower portion of the hole punch mechanism. The mechanical 
fixation ensures initial connection of the two vessels while the bioactive component reinforces the 
connection and ensures minimal leakage. The button activated approach ensures a simple and easy to 
understand process. 
       
Another design concept considered was one that entails modifying the EEA stapler (APPENDIX 
B) to perform side-to-side anastomosis attachments. In doing so, the applicator end that attaches to the 
anvil would be moved to the side of the stem. The anvil would have nitinol arms that could extend and 
contract based on temperature. Thus, the anvil would be kept in a cold saline bath that would cause the 
nitinol arms to contract, making the anvil small enough to be placed in a slit in the target vessel. Once the 
anvil warms to body temperature, the nitinol arms would extend, allowing the component to be stabilized 
and anchored in the vessel. The applicator would be placed through the end of a grafted vein at which 
point it would attach to the anvil and fire. Firing of the device would entail hole punching and releasing 
staples. The anvil would prevent the staples from puncturing the back side of the target vessel, and would 
cause the staple arms to fold over. At this point, the anastomosis site would have to be flushed with cold 
saline to cause the anvil arms to contract. This would allow the device with attached anvil to be pulled out 
of the grafted vein. The grafted vein would then have to be ligated. This design would effectively hold 
together the two vessels and achieve the goal of standardization. Refer to APPENDIX C.1 for a diagram 
of this solution.   
  
A nitinol clamp similar to the Medtronic, Inc. U-Clip was also proposed for side-to-side 
anastomosis procedures. This would entail two rings that are connected by nitinol wire. At cooler 
temperatures (in a cold saline bath), the nitinol wire would be straightened and the rings would be 
separated. This would allow the device to be placed through a slit on the side of both target vessels. At 
body temperature, the nitinol wire would bend such that the rings are brought together, effectively 
holding the vessels together. Refer to APPENDIX C.2 for appropriate drawings.  
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The final concept considered was a flared conduit, which was later refined to a lipped conduit, 
used in conjunction with mechanical and chemical fixations. Two tissue segments would be mounted in 
an end-to-end manner over the lipped ends onto the device stem until the segment ends contacted one 
another. Once the two ends of the intestines were touching, the BioGlue could be applied to the entire 
perimeter. The BioGlue would not only work to prevent leakage, but it will also promote the healing of 
the anastomosis site. A clamp would then be used to mechanically fix the conduit in place, and support 
the union of the two sides of the intestines. This simple approach achieves the desired ease of use 
stipulation. The double fixation method should ensure the efficacy of the connection. The conduit and 
clamp would be composed of 85:15 PLGA, a biodegradable material which would be excreted from the 
body after tissue union is achieved. The BioGlue will stimulate tissue union and be used by the 
surrounding tissues in that effort. The degradability and resorption of the materials will achieve the 
necessary longevity of the connection as they will allow for a newly formed tissue connection while 
leaving no foreign material within the body. PLGA is a co-polymer that is commonly used in the body as 
absorbable sutures, so this will ensure that there will be a minimal reaction to the foreign body. This 
method achieves the main goals necessitated by the stakeholder while maintaining an overall simplicity of 
design.  
  
The process for choosing the best product was grounded in the stakeholder needs and project 
constraints. When mechanical fixations are used that puncture the vessel and glue is applied, the glue will 
seep through the puncture. For this reason, devices combining glue and tissue punctures were eliminated 
(“Reinforced Fixation Anastomotic Punch”). On the other hand, the efficacy of glue alone to hold 
together two vessels alone could not be determined, so relying on a mechanical and adhesive connection 
seemed optimal. In addition, simplicity was stressed during the design selection process. To make a 
successful design, given the limiting constraint of time, the chosen device needed to be simple for ease of 
production, manufacturing, and testing. For a more comprehensive breakdown and screening matrix, see 
APPENDIX D. The screening procedure indicated that the conduit design with adhesive would most 
adequately address the stakeholder needs. However, certain modifications needed to be made to improve 
the efficacy and simplicity of the overall procedure. In an effort to eliminate the need to account for 
blood-contacting surfaces, the overall project was refined to apply to intestinal anastomosis. The full 
design description is described in the following section.  
 
 
PRODUCT DESCRIPTION 
 
Product General Description 
Once the decision was made to use the conduit design rather than the other methods described in 
the previous section, there were several factors we needed to examine in terms of the overall design. The 
first thing we had to decide was the length of the conduit. We wanted it to be large enough to allow 
passage for the necessary materials to pass through the bowel, while small enough to not stretch and 
damage the tissue. Along with the length and internal diameter of the conduit, we also had to decide on 
the diameter of the conduit lip. With this decision, we had to consider the fact that the lip needs to prevent 
leakage from the intestine by physically blocking the fluid and material from seeping into the area 
between the lips. We also, once again, did not want the pressure from the conduit to damage the tissue 
which could lead to future issues that will probably require surgery.  
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There are several key components that are incorporated into the conduit that are essential for its 
proper function. The first feature for the conduit is the lip design. The lip is essential for helping reduce 
the amount of movement of the conduit while implanted in the intestines. Though we are testing this 
device on the large bowel, it has potential to be incorporated into the small intestines, esophagus, and 
even vascular. With all of these locations, it is essential that the conduit stays in place and is not allowed 
to move. With that in mind, a larger diameter lip was incorporated into both ends of the conduit. This 
would work in cooperation with a clamp device that is applied around the intestines after the conduit is 
implanted and the glue is applied. Thus, the force from the intestines keeps the conduit in place, and the 
external clamp (with a diameter slightly less than that of the lips) makes it impossible for the conduit to 
move while the clamp is secure. Another essential function of the conduit lip is the reduction of contents 
from the intestine being able to interfere with the anastomosis site due to the tight space between the lips 
and the intestine, blocking matter from passage. With the internal components of the intestines being 
acidic or basic depending on the section, it is important for those materials not leak out. With that in 
mind, the conduit outer rims are designed to be slightly larger in diameter than the intestines (which 
works due to the elasticity of the intestines) so that the intestines can stretch over the conduit and be 
secure and tight at the site of the lips. This feature allows for minimal passage of contents into the space 
between the outer rims of the conduit, thus less interference at the site of anastomosis.  
 
Product Dimensions 
After doing research, we initially decided that the conduit lip needed to have a diameter of 3.5 
inches and the internal section needed a diameter of 3 inches. This was decided based on the average 
human intestine diameter of 3 inches. Upon receiving the prototype, we quickly determined this 
measurement was far too large. We reduced the diameter of the lips from 3.5 to 2.5 inches and the internal 
diameter from 3 to 2 inches. After doing a quick print using a basic desktop printer, we decided to reduce 
this even further to around 2.2 inches for the outer lip and 1.6 inches for the inner diameter. The 
appropriate device measurements were determined by using a pair of calipers to determine the diameter of 
porcine large intestines. Once the first round of testing was completed, we decided to keep the internal 
diameter the same while reducing the outer diameter to 1.95 inches. These were the dimensions used in 
the final round of testing for our prototype device and the final conduit can be seen in Figure 2.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Final Conduit Design. Final design of the conduit, to be placed inside the intestines. 
This component has an internal facing lumen and an external facing intestinal wall. 
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Product Material and Degradation Properties 
Another key concept for the device is the material that is used for the conduit and clamp assembly 
(Figure 3). The first decision that had to be made was whether or not we wanted the assembly to be 
permanent or not. If permanent, the device would have to be sufficiently biocompatible to maintain 
viability in the body long-term, and the foreign body response would need to be minimal. If not 
permanent, it must be degradable so that only one surgery is needed, and it must degrade within a time 
frame that allows enough time for the anastomosis to be complete. The initial decision was to make the 
device permanent and use Polytetrafluoroethylene (PTFE) due to its superior biocompatibility, low 
coefficient of friction (allowing material in the lumen of the intestines to adequately pass through), and 
lack of reaction with tissue. Upon discussion with Dr. Lee, however, it was decided to make the device 
biodegradable. After careful research, it was decided to use Poly Lactic-co-Glycolic Acid (PLGA) 
copolymer. The advantage of using PLGA is the ability to tailor device properties by altering polymer 
composition (PGA is more amorphous and degrades quickly in the body while PLA is more crystalline 
and has a lower degradation rate). Thus, when combined into a copolymer, the degradation rate can be 
manipulated based on the composition. Upon research, it was decided that PLGA 85:15 would be used. 
With PLGA 85:15, the degradation rate is around 6-8 months22, which gives plenty of time for the 
anastomosis to be complete. The final device will be mass-produced using injection molding, which 
allows for relatively cheap production in a time efficient manner after the initial investment of the molds. 
 
 
Figure 3. Final Design of the Conduit-Clamp Assembly. Once in place, the intestines would 
wrap around the conduit and BioGlue® would be applied. After the BioGlue® sets, the clamp 
assembly would be administered. 
 
Another key component to the device in terms of degradation are the channels implemented into 
the conduit. Since the conduit is designed to degrade in the intestines, the degradation must be controlled 
so that large chunks don’t degrade off that could be sharp and cause damage or even blockage further 
downstream. With that in mind, it is very important that we manipulate the design of the conduit so that 
the chunks from degradation are not too large inside of the intestines. Channels were incorporated on the 
internal surface of the conduit so that certain portions of the conduit were thinner and would thus degrade 
faster. These channels were designed so that the conduit would degrade into small square pieces rather 
than large chunks. These small square pieces would have no trouble being passed through as opposed to 
the large chunks, thus reducing further possible damage. 
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As discussed earlier, one of the main features of this device is the two-part system of a clamp and 
conduit. The clamp is composed of the same 85:15 PLGA copolymer and is placed on the outside of the 
intestines in order to secure the conduit in place. When designing the clamps, the initial design was a 
single piece clamp that relied on a small amount of force from the surgeon by pressing the opening to the 
section of the intestines (with the conduit inside) so that the clamp would deform and slide over the 
conduit and then spring back into place once the opening reached the other side of the conduit. An 
illustration of this initial clamp is shown in APPENDIX E. After discussion with Dr. Lee, we were 
unsure if this design would lead to tissue damage due to the force placed on the intestines against the 
conduit and it was decided to explore other options for the application of the conduit. That led to the 
development of the two-part hinged clamp which allows for minimal force to be placed on the intestines 
during application while also maintaining a secure fit with minimal possibility of displacement.  
 
The hinged clamp is composed of two parts, each with male and female pieces that when attached 
at one end, create the hinge. Once the hinged clamp is attached at the other end, it allows for minimal 
movement, thus, providing a secure clamp when place on the outside of the conduit. The design of the 
clamps male parts include a fillet at the base in order to provide high strength and prevent them from 
breaking off and the same fillet was then added to the female part in order to allow for the male part to fit. 
The hinged clamp design gives the surgeon great ease of use when applying the device and only a 
minimal amount of force by the surgeon is needed for application. The clamp fits around the central 
portion of the conduit and the diameter of the clamp (when in place) is less than the diameter of the 
conduit lip, making it impossible for the conduit to pass through the clamp. Supports are added to the 
outer clamp component (Figure 4A) that are on the outside of the fixture so that only the inner clamp 
component (Figure 4B) must be deformed when applying to reduce possibility of them coming apart.  
 
 
Figure 4A and 4B. Final Design of the two-part clamp system. The final clamp has two 
components that are both applied to the outside of the intestines and hold the conduit in place. A. 
The component on the left is the outer clamp component. B The figure on the right is the inner 
clamp component. 
 
The final key component of the design is the application of the tissue adhesive on the outside of the 
anastomosis site which allows for the ends of the intestines to be held in place and touching one another 
in order to promote closure. This also provides an additional protection from leakage of the intestinal 
contents which further reduces the chance of an additional surgery being needed and infection. The first 
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adhesive looked into was TissueGlue, but with little testing being done on the intestinal area and high 
cost, we decided on CryoLife BioGlue® (Figure 5) instead. CryoLife BioGlue® has been used on soft 
tissue and intestines in Europe and would provide a way to prevent leakage for our device as well as make 
sure the ends are held tightly together to promote growth. Testing was done on the intestines with and 
without the conduit and it was determined that the BioGlue was capable of withstanding over 15 Newtons 
of force for both tests and prevented any leakage from occurring. As a result, BioGlue was determined to 
be a suitable adhesive for our device. 
 
 
Figure 5. CryoLife BioGlue® and Applicator. This tissue adhesive would be applied to the 
intestines once they have been wrapped over the conduit. This provides an extra layer of 
protection against leakage.  
 
 
DESIGN EVALUATION  
               The various requirements the device was to meet required a range of verification methods. These 
verification methods included materials research, device assembly practice, and basic testing. The 
materials research was performed to gather information on our intended final design material (PLGA 
85:15) and to find a comparable prototype material for testing. Eventually it was determined from 
available literature that PLGA 85:15 is an FDA approved material with a degradation time of 6-8 months. 
This met our requirement of biocompatibility as the material has previously been proven to result in no 
significant detrimental host response. The material also meets the requirements of degradability as well as 
durability as it degrades in 6-8 months which is well outside the necessary window for anastomotic 
healing. As the anastomosis connection will have unionized prior to the theoretical degradation of the 
conduit, the durability is ensured throughout the healing process. Additionally, PLGA 85:15 can be 
injection molded, providing an easily translatable mass production method for a final product at costs as 
low as approximately $367 per device. Initial production costs would be around $2,100 per device, but 
this is predicted to drop steeply to the mass production estimate. While the basic research is sufficient for 
initial prototype direction, actual degradation studies would need to be performed to ascertain the true 
degradation rate of our device given its unique architecture. 
            It was also determined that an ABS/polypropylene blend available from Protolabs® by the name 
of Accura® Xtreme™ White 200 possessed mechanical properties comparable to PLGA 85:15. This led 
to its use as the material from which the final prototype was produced, illustrated in Table 2. This final 
prototype was the device used for testing the remaining needs including ease of use, comparable 
application time, efficacy, and leakage reduction. Prototype costs are consistent and remain around $500 
per entire device assembly. 
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Table 2. Material Property Comparison Chart. Comparison of the material properties and 
elasticity of the human intestines and device materials. 85:15 PLGA corresponds to the theoretical, 
final design material and Accura® Xtreme™ White 200 corresponds to the prototype material. 
 Human Large Intestines 23, 24 85:15 PLGA
25 Accura® Xtreme™ White 
200 26 
Young’s Modulus (MPa) 0.9 - 5.18 2.0 x 103 2.4 x 103 
Elongation (%) 80 - 180 3 - 5 7 - 20 
 
Concerning the standardization, ease of use, and time of application, the Team Connect members 
each performed an anastomotic simulation, with another team member’s assistance, with our device 
procedure and assembly using porcine intestines. The time from simulation initiation to complete device 
application for each team member stayed at approximately 3 minutes. Despite the limited sample pool, 
simulation completion times averaging 3 minutes using unskilled workers lends to the belief that surgeons 
in the operating room could improve on, or at the very least match, this application time. As the 
applications times were similarly short across all members, the device and application process were 
demonstrated to be simple, easy to implement, comparable to duration of current methods, and capable of 
standardization. 
            Additionally, the efficacy of the device had to be tested concerning its durability against internal 
forces and its resistance to leakage. In order to test the assembly’s ability to withstand forces and resist 
rupture at the site of intestinal union, the full assembly, with mounted intestines, was subjected to tensile 
forces. The test was administered by attaching a luggage scale to the far end of one of the attached 
intestinal segments. The scale was attached to the segment by using the scale’s prongs to pierce the 
intestinal wall and then wrapping the far end of the segment around the prongs of the scale to further 
secure the connection. The scale was mounted onto a secure lab station, and the intestinal segment 
mounted to the other side of the conduit was slowly pulled by hand until the intestinal connection 
ruptured. Six tensile tests were performed with comparable results. In each case, the intestines began 
tearing at the luggage scale prior to rupture of the intestinal connection. The final force required to rupture 
the bond at the connection site was approximately 25 N across all tests. As the intestines themselves 
began to tear prior to bond rupture, it is safe to assume that the bold will hold strong, at least in the face of 
mechanical forces, within the intestinal environment. 
            As a bioadhesive was used to secure the intestinal connection at the center point, additional 
tensile testing was required to determine the device’s contribution. The tensile testing was performed 
without the device assembly, and the only factor securing the connection was the adhesive. The tests were 
performed in the same manner mentioned above, and the force required to rupture the connection was 
approximately 17.5 N. As this rupture force is smaller than the one found when the full device assembly 
has been implemented within the anastomosis, it can be assumed that the conduit and clamp of the 
assembly further secure and reinforce the connection. 
            Also, as the device will be used to attach intestinal segments, it must provide a sound and secure 
connection to prevent leakage of any intestinal fluids. To determine the device’s ability to prevent leakage 
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of any fluid, the simulated anastomosis was performed with the intestinal segments, and then fluids were 
sent through the length of the mounted intestines by manual pouring into an elevated intestine position. 
Leaked fluids were to be collected within a graduated beaker positioned directly below the connection; 
however, upon testing with proper application, no fluids were leaked. The two fluids tested were water 
and a chocolate cookie milkshake to provide varied possible viscosities. Some leakage was witnessed on 
one run where the adhesive had not been applied entirely around the connection. This suggests that the 
lips of the conduit should be expanded to provide a tighter seal at the ends of the mounted intestinal 
portions to reduce reliance on the bioadhesive used. 
            Finally, as all patients will not conform to a single intestinal diameter, it is imperative to provide 
a sizing solution. Due to the nature of the production methods to be implemented, several sizes and 
iterations can easily be produced and kept in stock in large quantities. An inventory should be kept of 
available sizes, and the appropriate size-match should be used once the patient’s intestinal dimensions are 
determined by either imaging prior to surgery or an additional sizer device used during surgery. The sizer 
device would be a conical shape with a stepwise increase in diameters which could be inserted into the re-
sectioned intestines to determine the required corresponding conduit assembly. Simple calipers should be 
used to determine intestinal wall thickness. The conical sizer device will allow for patient specific conduit 
assembly sizing and will allow for an appropriate fit to meet our previously mentioned requirements. 
 
 
RECOMMENDATIONS & FUTURE WORK  
 
 This product has been able to circumvent all of the pitfalls associated with the products and 
procedures that are in use today. Not only is this device extremely easy to use, it is effective.  The issue of 
stricture is mitigated by the internal conduit that will hold the anastomosis site open while the healing 
occurs. This product will also reduce leakage. There was no leakage observed with our device when water 
and a thicker medium (a milkshake) was used. This assures us that viscous or more watery sections of 
waste will not be able to leak out of the site while it heals. Our tensile tests have also assured us that there 
will be no failure of the BioGlue/conduit combination due to any stresses that the body will be able to put 
on the assembly. This is because the BioGlue alone failed at 17.5N, and when the assembly was tried, the 
integrity of the intestines failed first.  
 
Additionally, this method is also time effective. Each assembly time took roughly 3 minutes to 
complete, which is similar to the amount of time it takes to deploy staplers and it is faster than the hand 
suturing method. This provided support that the design can standardize the anastomosis process. Finally, 
this device is cost effective. Once the molds are created, the cost for the raw materials to create the 
product will cost about $2,100 when the material is not purchased at bulk price. When the device is mass 
produced, the cost for the raw material will be greatly decreased, decreasing the price of each assembly.   
 
 The future of this product will involve improving the ergonomics of the device and overall 
refinement of the design. The initial refinement would be to find the perfect balance of how tall the lips of 
the conduit should be to create an adequate seal around the intestines, but to not stretch them too far and 
cause necrosis. This would involve getting a better estimate of the diameter of the intestines with and 
without waste in them, to observe the state that the surgeon would be administering the device in and to 
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also see how our device would work when the intestines are in their natural state.  Further, this would 
involve creating various sizes for the different sizes of intestines encountered, and eventually for different 
surgeries (esophageal, gastric bypass, small bowel, etc.) Additionally, we would need to find a way to 
effectively characterize the different sizes and which assembly would be needed for each size. This could 
either be achieved through imaging or with a completely separate device that would be used in the 
operating room. 
 
There is still further testing that needs to be performed to ensure the success of this device. 
Degradation tests need to be performed to observe how the conduit and the clamp will degrade since one 
will be inside the intestine and one will be outside of the intestine. The inflammatory response to this 
material will also need to be measured. Another important test would to be to find the most effective 
sterilization method for our device.  Ethylene oxide and irradiation methods are both used on this material 
to sterilize it, but tests on the most efficient method that can be used without harming the integrity of the 
product would be needed in the future.   
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APPENDIX A 
 
While doing research for this project, we knew that there were many existing products on the 
market already.  We decided that the best way for us to tackle this problem would be for us to see what 
has already been done and analyze the strengths and weaknesses of all of the other products. After 
analyzing these products, we would attempt to combine all of them in a way to eliminate most of the 
weaknesses.  This gives us a better understanding of what works and what will not work, as well.  A few 
of the various products that we researched include: Periclose, Inc. Heartflo device, Medtronic, Inc. U-
Clip, United States Surgical Corporation One-Shot system, St. Jude Medical ATG Distal Coronary 
Connector, and St. Jude Medical Symmetry Bypass System Aortic Connector.   
 
Periclose, Inc. Heartflo device:  While using this device, the sutures still have to be tied after the 
device is used, which only eliminates a couple of steps that the surgeon has to perform.  This also means 
that this device is not completely automated.  Arteries smaller than 1.8mm cannot be used, which is a 
major limitation of this device.  The “square-shaped foot” of the device is cumbersome to use with small 
vessels.  Supplementary stitches are needed to achieve complete hemostasis, which, again, means that the 
device is not fully automated.  One strength of this device is that it does leave less endovascular material 
behind than other devices do.  Some of the weaknesses of this device include: no procedure time 
difference compared to hand-suturing (15-22 min.), extensive handling, size limitation, shape, additional 
suturing required.   
 
Medtronic, Inc. U-Clip: The U-Clip is a device manufactured by Medtronic.  The mean usage 
time was about 8.6 minutes, which is comparable to the time it takes to hand suture.  The device is 
relatively easy to use, as reported by studies of surgeons that have used this device.  This device requires 
no additional knot tying.  There is a concern about this device due to nitinol allergies of some patients, 
which may be unknown until the device is implanted.  This device also comes with a higher cost.  Some 
of the major strengths of this device are that it is useful for distal and proximal anastomosis procedures, it 
has excellent clinical patency, and interrupted anastomosis causes less deformation.  Nitinol is a 
superelastic, shape memory alloy that allows a device to be deformed, but return to its original shape after 
warming to body temperature. However, the weaknesses of this device include the nitinol allergies and 
the higher cost associated with the device. The design team considered a nitinol clamp that would hold the 
two vessels together.  
 
United States Surgical Corporation One-Shot system: The One-Shot Device creates rapid and 
reproducible constructs.  This device can be used in vessels as small as 1.8mm, which is a limitation since 
these vessels may be much smaller.  The device has reported that diseased artery would be prone to 
dissection, which is a major problem because most of the patients that would require this device would 
have diseased arteries.  Due to this, the device requires a flexible arterial wall.  There is also a learning 
curve associated with this device, which many doctors would be hesitant in committing time to.  The 
proximal side has to be done first and it leaves the distal end free.  
 
St. Jude Medical ATG Distal Coronary Connector: This device consists of a stainless steel clip 
that is attached to a balloon delivery catheter. The balloon design provides expansion/contraction 
capabilities of the device and provides the device’s deployment mechanism. The catheter is inserted 
through the distal end of the conduit and advanced to the anastomosis site on the vein. A small incision 
should be made at this site, and the catheter is slid through the hole. The balloon is subsequently inflated 
and the stainless steel connectors are deployed, thus attaching to the conduit. A small incision is then 
made in the coronary artery and the nosecone of the device is advanced, exposing the other end of the of 
the connectors. Expanding the balloon causes the hooks to attach to the artery and join the vessels 
together, at which point that catheter system can be removed and the end of the conduit is ligated.  The 
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strengths of this device are the short loading/preparation time (~2 min.), the short deployment/procedure 
time (~2 min.), there is instantaneous hemostasis, and maintained appropriate fluid flow.  The weakness 
of this device include the minimum diameter of 2.0 mm, stainless steel connectors require careful 
handling to prevent distortion, 1 in 5 had to be removed due to leakage, there is a potential foreign body 
response due to introduction of foreign material into intima of vessels, endothelial damage.   
 
St. Jude Medical Symmetry Bypass System Aortic Connector is a device that can connect grafts 
with diameters from 4.5mm to 6mm.  There is no clamping of the aorta necessary to use this device. The 
time to complete the mechanical anastomosis was 10 seconds; loading time takes up to 16 minutes, which 
is comparable to the amount of time that it takes to hand suture.  This device is reliable and easy to 
handle.  The aortic puncher used creates round holes. The graft must be administered at a 90 degree angle 
from the aorta, limiting the number of grafts that can be performed and can possibly lead to kinking of the 
graft. 
 
Almost all intestinal anastomoses are currently performed using staplers.  These devices provide a 
quick and easy way to create an anastomosis, especially when used laparoscopically.  Some issues 
associated with these devices are that there is a great amount of shear stress that is put on the tissues when 
staples are used.  They are generally made out of a material that is not biodegradable, so they will stay in 
the body and have the potential to create a foreign body response at the anastomosis site.  There is also 
the possibility of the staples misfiring or missing the target tissue, making them ineffective.  If this 
happens, or the stress put on these staples is too great, there is a chance that the anastomosis site could 
open up and there could be leakage from the intestines to the area outside, which could create many 
problems.  This increases the chances that the patient will have to have another surgery, and it opens them 
up to an added risk of infection.  For these anastomoses, there is not so much a risk that they will occlude, 
but there is a potential that they will shrink in diameter at the site of the anastomosis, which makes the 
chance of a blockage occurring greater.  There needs to be a better, more efficient way to create these 
anastomoses. 
 
Medtronic, Inc. EEA Stapler is a stapler that is used for end-to-end anastomosis for colorectal 
procedures. This device is a two component system, consisting of the staple applicator and an anvil. The 
anvil is placed in the end of the target vessel, such that the tip is pointed towards the other vessel being 
attached. The applicator is a device with a long stem and attachment mechanism at the end. 
 
 OptiFlow® Vascular Anastomotic System has received CE approval and is intended to be used 
for hemodialysis.18-21 The conduit design is made of a non-thrombogenic siliconized polyurethane that has 
ridges allowing it to be placed inside the vein and a flanged end that is placed inside the artery. Users of 
this device have reported standardized, shortened procedure times without thrombosis or leakage.18-20 
However, there is still concern regarding dislodging and long-term efficacy.21   
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APPENDIX B 
 
[1] DST Series™ EEA™ Staplers (http://www.medtronic.com/covidien/products/surgical-
stapling/circular-staplers) 
[2] DST Series™ EEA™ Stapler in use for Colorectal Surgery 
(http://www.coloproctol.org/search.php?where=aview&id=10.3393/jksc.2008.24.1.62&code=0009JKSC
&vmode=PUBREADER) 
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APPENDIX C.1 
 
 
 
 
 
APPENDIX C.2  
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APPENDIX D 
 
Biocompatibility, suture/staple-less, ease of use, efficacy, and simplicity were chosen as primary 
categories by which to “grade” the designs. Each of these categories appropriately reflects stakeholder 
needs and constraints of the project. Devices that entailed leaving nitinol in the body were graded 
moderately for biocompatibility due to the potential of nickel allergies. Ease of use was determined by 
estimating the number of components that the surgeon would have to interact with to perform the 
anastomosis procedure. Simplicity was graded by analyzing the number of components and materials 
comprising the system and estimating the level of difficulty in manufacturing and refining the design. For 
efficacy, devices that solely relied on staples for the attachment were graded poorly. Devices that only 
relied on glue or entailed combining glue with puncture mechanisms were graded moderately due to 
question about the efficacy of adhesives. The inverse scissors were graded “n/a” for biocompatibility and 
suture/staple-less because they are not intended to be left in the body. In addition, the were graded “No” 
for efficacy because they are not involved in actually holding vessels together. Thus, it can be seen that 
the conduit design best addresses each of the needs and constraints.  
 
 
  Biocompatible Suture/ 
Staple-less 
Ease of Use Predicted 
Attachment 
Efficacy 
Simplicity 
Inverse 
Scissors 
n/a n/a Yes No Moderately 
Nitinol 
Clamps 
Moderately Yes Yes Moderately Moderately 
Modified 
EEA 
Yes No Moderately No No 
Balloon with 
Bioglue 
Yes Yes Moderately Moderately Moderately 
Conduit Yes Yes Yes Yes Yes 
Reinforced 
Stent 
Yes Yes Yes Moderately Moderately 
Reinforced 
Anastomotic 
Punch 
Yes Moderately Yes Moderately No 
 
 
Final Design Report                          Team Connect 
23 
APPENDIX E 
 
Initial Clamp and Assembly 
 
 
